胰岛素的全球市场 2023-2027
市场调查报告书
商品编码
1180100

胰岛素的全球市场 2023-2027

Global Insulin Market 2023-2027

出版日期: | 出版商: TechNavio | 英文 154 Pages | 订单完成后即时交付

价格

胰岛素的市场规模在2022年~2027年间,预测将成长到16亿6,241万美元,在预测期间内预计将以年复合成长率1.77%增长。

本报告提供胰岛素市场整体分析,提供市场规模与预测,趋势,成长促进因素·课题,网罗了约25家供应商的供应商分析。

同时本报告还提供当前全球市场趋势与推动因素以及整体市场环境的最新分析。市场成长的主要因素有糖尿病的盛行率增加,暴露在糖尿病危险因素的机会增加,政府的有利配合措施。

目录

第1章 摘要整理

  • 市场概要

第2章 市场形势

  • 市场生态系统

第3章 市场规模

  • 市场定义
  • 市场区隔分析
  • 市场规模 2022
  • 市场预测:2022-2027年的预测

第4章 市场规模实际成果

  • 全球胰岛素市场2017~2021年
  • 类型市场区隔分析2017-2021
  • 流通管道市场区隔分析2017-2021
  • 地区市场区隔分析2017-2021
  • 国家市场区隔分析2017-2021

第5章 波特的五力分析

  • 五力的摘要
  • 买方议价能力
  • 供给企业谈判力
  • 新加入厂商业者的威胁
  • 替代品的威胁
  • 竞争的威胁
  • 市场情况

第6章 各类型的市场区隔

  • 市场·市场区隔
  • 各类型比较
  • 胰岛素类似物 - 市场规模与预测 2022-2027
  • 胰岛素注射液 - 市场规模与预测 2022-2027
  • 各类型的市场机会

第7章 各流通管道市场区隔

  • 市场·市场区隔
  • 各流通管道比较
  • 零售药局 - 市场规模与预测 2022-2027
  • 医院 - 市场规模与预测 2022-2027
  • 线上药局 - 市场规模与预测 2022-2027
  • 各流通管道的市场机会

第8章 客户形势

  • 客户形势概要

第9章 各地区形势

  • 各地区市场区隔
  • 各地区比较
  • 北美 - 市场规模与预测 2022-2027
  • 欧洲 - 市场规模与预测 2022-2027
  • 亚洲 - 市场规模与预测 2022-2027
  • 其他地区(ROW) - 市场规模与预测 2022-2027
  • 美国 - 市场规模与预测 2022-2027
  • 英国 - 市场规模与预测 2022-2027
  • 德国 - 市场规模与预测 2022-2027
  • 中国 - 市场规模与预测 2022-2027
  • 日本 - 市场规模与预测 2022-2027
  • 各地区形势的市场机会

第10章 促进因素,课题,及趋势

  • 推动市场要素
  • 市场课题
  • 推动因素与课题的影响
  • 市场趋势

第11章 业者情势

  • 概要
  • 业者情势
  • 混乱状况
  • 产业的风险

第12章 供应商分析

  • 交易厂商
  • 供应商的市场定位
  • B. Braun SE
  • Becton Dickinson and Co.
  • Biocon Ltd.
  • Cardinal Health Inc.
  • CODAN Medizinische Gerate GmbH and Co KG
  • Eli Lilly and Co.
  • Gerresheimer AG
  • Gulf Pharmaceutical Industries
  • Hindustan Syringes and Medical Devices Ltd.
  • Mayo Foundation for Medical Education and Research
  • Nipro Corp.
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi SA
  • Wockhardt Ltd.

第13章 附录

Product Code: IRTNTR74807

Technavio has been monitoring the insulin market and is forecast to grow by $1662.41 mn during 2022-2027, accelerating at a CAGR of 1.77% during the forecast period. Our report on the insulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of diabetes, increasing exposure to risk factors that lead to diabetes, and favorable government initiatives.

Technavio's insulin market is segmented as below:

By Type

  • Insulin analog
  • Human insulin

By Distribution Channel

  • Retail pharmacies
  • Hospitals
  • Online pharmacies

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advances in insulin delivery systems as one of the prime reasons driving the insulin market growth during the next few years. Also, increasing focus on home care settings and an increase in awareness of diabetes and growth initiatives will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the insulin market covers the following areas:

  • Insulin market sizing
  • Insulin market forecast
  • Insulin market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insulin market vendors that include AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., Mayo Foundation for Medical Education and Research, Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., Wockhardt Ltd., and Nipro Corp. Also, the insulin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global insulin market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global insulin market 2017 - 2021 ($ million)
  • 4.2 Type Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • 4.3 Distibution channel Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Distibution channel Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
  • 6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
  • 6.3 Insulin analog - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Insulin analog - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Insulin analog - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Insulin analog - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Insulin analog - Year-over-year growth 2022-2027 (%)
  • 6.4 Human insulin - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Human insulin - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Type
  • Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

  • 7.1 Market segments
  • Exhibit 43: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibit 44: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • 7.2 Comparison by Distribution Channel
  • Exhibit 45: Chart on Comparison by Distribution Channel
  • Exhibit 46: Data Table on Comparison by Distribution Channel
  • 7.3 Retail pharmacies - Market size and forecast 2022-2027
  • Exhibit 47: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 50: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • 7.4 Hospitals - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
  • 7.5 Online pharmacies - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Distribution Channel
  • Exhibit 59: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 63: Chart on Geographic comparison
  • Exhibit 64: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 UK - Market size and forecast 2022-2027
  • Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.9 Germany - Market size and forecast 2022-2027
  • Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.10 China - Market size and forecast 2022-2027
  • Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 104: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 105: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 106: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 107: Matrix on vendor position and classification
  • 12.3 B. Braun SE
  • Exhibit 108: B. Braun SE - Overview
  • Exhibit 109: B. Braun SE - Business segments
  • Exhibit 110: B. Braun SE - Key news
  • Exhibit 111: B. Braun SE - Key offerings
  • Exhibit 112: B. Braun SE - Segment focus
  • 12.4 Becton Dickinson and Co.
  • Exhibit 113: Becton Dickinson and Co. - Overview
  • Exhibit 114: Becton Dickinson and Co. - Business segments
  • Exhibit 115: Becton Dickinson and Co. - Key news
  • Exhibit 116: Becton Dickinson and Co. - Key offerings
  • Exhibit 117: Becton Dickinson and Co. - Segment focus
  • 12.5 Biocon Ltd.
  • Exhibit 118: Biocon Ltd. - Overview
  • Exhibit 119: Biocon Ltd. - Business segments
  • Exhibit 120: Biocon Ltd. - Key offerings
  • Exhibit 121: Biocon Ltd. - Segment focus
  • 12.6 Cardinal Health Inc.
  • Exhibit 122: Cardinal Health Inc. - Overview
  • Exhibit 123: Cardinal Health Inc. - Business segments
  • Exhibit 124: Cardinal Health Inc. - Key news
  • Exhibit 125: Cardinal Health Inc. - Key offerings
  • Exhibit 126: Cardinal Health Inc. - Segment focus
  • 12.7 CODAN Medizinische Gerate GmbH and Co KG
  • Exhibit 127: CODAN Medizinische Gerate GmbH and Co KG - Overview
  • Exhibit 128: CODAN Medizinische Gerate GmbH and Co KG - Product / Service
  • Exhibit 129: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
  • 12.8 Eli Lilly and Co.
  • Exhibit 130: Eli Lilly and Co. - Overview
  • Exhibit 131: Eli Lilly and Co. - Product / Service
  • Exhibit 132: Eli Lilly and Co. - Key offerings
  • 12.9 Gerresheimer AG
  • Exhibit 133: Gerresheimer AG - Overview
  • Exhibit 134: Gerresheimer AG - Business segments
  • Exhibit 135: Gerresheimer AG - Key news
  • Exhibit 136: Gerresheimer AG - Key offerings
  • Exhibit 137: Gerresheimer AG - Segment focus
  • 12.10 Gulf Pharmaceutical Industries
  • Exhibit 138: Gulf Pharmaceutical Industries - Overview
  • Exhibit 139: Gulf Pharmaceutical Industries - Product / Service
  • Exhibit 140: Gulf Pharmaceutical Industries - Key offerings
  • 12.11 Hindustan Syringes and Medical Devices Ltd.
  • Exhibit 141: Hindustan Syringes and Medical Devices Ltd. - Overview
  • Exhibit 142: Hindustan Syringes and Medical Devices Ltd. - Product / Service
  • Exhibit 143: Hindustan Syringes and Medical Devices Ltd. - Key offerings
  • 12.12 Mayo Foundation for Medical Education and Research
  • Exhibit 144: Mayo Foundation for Medical Education and Research - Overview
  • Exhibit 145: Mayo Foundation for Medical Education and Research - Product / Service
  • Exhibit 146: Mayo Foundation for Medical Education and Research - Key offerings
  • 12.13 Nipro Corp.
  • Exhibit 147: Nipro Corp. - Overview
  • Exhibit 148: Nipro Corp. - Business segments
  • Exhibit 149: Nipro Corp. - Key offerings
  • Exhibit 150: Nipro Corp. - Segment focus
  • 12.14 Novo Nordisk AS
  • Exhibit 151: Novo Nordisk AS - Overview
  • Exhibit 152: Novo Nordisk AS - Business segments
  • Exhibit 153: Novo Nordisk AS - Key offerings
  • Exhibit 154: Novo Nordisk AS - Segment focus
  • 12.15 Pfizer Inc.
  • Exhibit 155: Pfizer Inc. - Overview
  • Exhibit 156: Pfizer Inc. - Product / Service
  • Exhibit 157: Pfizer Inc. - Key news
  • Exhibit 158: Pfizer Inc. - Key offerings
  • 12.16 Sanofi SA
  • Exhibit 159: Sanofi SA - Overview
  • Exhibit 160: Sanofi SA - Business segments
  • Exhibit 161: Sanofi SA - Key news
  • Exhibit 162: Sanofi SA - Key offerings
  • Exhibit 163: Sanofi SA - Segment focus
  • 12.17 Wockhardt Ltd.
  • Exhibit 164: Wockhardt Ltd. - Overview
  • Exhibit 165: Wockhardt Ltd. - Business segments
  • Exhibit 166: Wockhardt Ltd. - Key offerings
  • Exhibit 167: Wockhardt Ltd. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 168: Inclusions checklist
  • Exhibit 169: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 170: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 171: Research methodology
  • Exhibit 172: Validation techniques employed for market sizing
  • Exhibit 173: Information sources
  • 13.5 List of abbreviations
  • Exhibit 174: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global insulin market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Distibution channel Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Type - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Type - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Insulin analog - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Insulin analog - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Insulin analog - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Insulin analog - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Human insulin - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Type ($ million)
  • Exhibits43: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits44: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits45: Chart on Comparison by Distribution Channel
  • Exhibits46: Data Table on Comparison by Distribution Channel
  • Exhibits47: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibits52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Market opportunity by Distribution Channel ($ million)
  • Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits63: Chart on Geographic comparison
  • Exhibits64: Data Table on Geographic comparison
  • Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Market opportunity By Geographical Landscape ($ million)
  • Exhibits102: Impact of drivers and challenges in 2022 and 2027
  • Exhibits103: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits104: Overview on factors of disruption
  • Exhibits105: Impact of key risks on business
  • Exhibits106: Vendors covered
  • Exhibits107: Matrix on vendor position and classification
  • Exhibits108: B. Braun SE - Overview
  • Exhibits109: B. Braun SE - Business segments
  • Exhibits110: B. Braun SE - Key news
  • Exhibits111: B. Braun SE - Key offerings
  • Exhibits112: B. Braun SE - Segment focus
  • Exhibits113: Becton Dickinson and Co. - Overview
  • Exhibits114: Becton Dickinson and Co. - Business segments
  • Exhibits115: Becton Dickinson and Co. - Key news
  • Exhibits116: Becton Dickinson and Co. - Key offerings
  • Exhibits117: Becton Dickinson and Co. - Segment focus
  • Exhibits118: Biocon Ltd. - Overview
  • Exhibits119: Biocon Ltd. - Business segments
  • Exhibits120: Biocon Ltd. - Key offerings
  • Exhibits121: Biocon Ltd. - Segment focus
  • Exhibits122: Cardinal Health Inc. - Overview
  • Exhibits123: Cardinal Health Inc. - Business segments
  • Exhibits124: Cardinal Health Inc. - Key news
  • Exhibits125: Cardinal Health Inc. - Key offerings
  • Exhibits126: Cardinal Health Inc. - Segment focus
  • Exhibits127: CODAN Medizinische Gerate GmbH and Co KG - Overview
  • Exhibits128: CODAN Medizinische Gerate GmbH and Co KG - Product / Service
  • Exhibits129: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
  • Exhibits130: Eli Lilly and Co. - Overview
  • Exhibits131: Eli Lilly and Co. - Product / Service
  • Exhibits132: Eli Lilly and Co. - Key offerings
  • Exhibits133: Gerresheimer AG - Overview
  • Exhibits134: Gerresheimer AG - Business segments
  • Exhibits135: Gerresheimer AG - Key news
  • Exhibits136: Gerresheimer AG - Key offerings
  • Exhibits137: Gerresheimer AG - Segment focus
  • Exhibits138: Gulf Pharmaceutical Industries - Overview
  • Exhibits139: Gulf Pharmaceutical Industries - Product / Service
  • Exhibits140: Gulf Pharmaceutical Industries - Key offerings
  • Exhibits141: Hindustan Syringes and Medical Devices Ltd. - Overview
  • Exhibits142: Hindustan Syringes and Medical Devices Ltd. - Product / Service
  • Exhibits143: Hindustan Syringes and Medical Devices Ltd. - Key offerings
  • Exhibits144: Mayo Foundation for Medical Education and Research - Overview
  • Exhibits145: Mayo Foundation for Medical Education and Research - Product / Service
  • Exhibits146: Mayo Foundation for Medical Education and Research - Key offerings
  • Exhibits147: Nipro Corp. - Overview
  • Exhibits148: Nipro Corp. - Business segments
  • Exhibits149: Nipro Corp. - Key offerings
  • Exhibits150: Nipro Corp. - Segment focus
  • Exhibits151: Novo Nordisk AS - Overview
  • Exhibits152: Novo Nordisk AS - Business segments
  • Exhibits153: Novo Nordisk AS - Key offerings
  • Exhibits154: Novo Nordisk AS - Segment focus
  • Exhibits155: Pfizer Inc. - Overview
  • Exhibits156: Pfizer Inc. - Product / Service
  • Exhibits157: Pfizer Inc. - Key news
  • Exhibits158: Pfizer Inc. - Key offerings
  • Exhibits159: Sanofi SA - Overview
  • Exhibits160: Sanofi SA - Business segments
  • Exhibits161: Sanofi SA - Key news
  • Exhibits162: Sanofi SA - Key offerings
  • Exhibits163: Sanofi SA - Segment focus
  • Exhibits164: Wockhardt Ltd. - Overview
  • Exhibits165: Wockhardt Ltd. - Business segments
  • Exhibits166: Wockhardt Ltd. - Key offerings
  • Exhibits167: Wockhardt Ltd. - Segment focus
  • Exhibits168: Inclusions checklist
  • Exhibits169: Exclusions checklist
  • Exhibits170: Currency conversion rates for US$
  • Exhibits171: Research methodology
  • Exhibits172: Validation techniques employed for market sizing
  • Exhibits173: Information sources
  • Exhibits174: List of abbreviations